Canadian Journal of Cardiology

Mitral Valve-in-Valve Over “Invisible” Prothesis With Thrombus Guided by CT-Fluoro Fusion

Published:April 12, 2022DOI:
      A 76-year-old woman with a history of permanent atrial fibrillation, chronic kidney disease (stage IV), and rheumatic heart valve disease with aortic and mitral surgical replacement (Labcor 19 and 27) and tricuspid annuloplasty in 2018 was admitted due to heart failure. Echocardiography showed prosthetic mitral valve dysfunction with severe regurgitation. After discussion, the Heart Team decided to perform valve-in-valve (ViV) owing to high risk (Society of Thoracic Surgeons score 10.13%, EuroScore II 8.78%) and previous breast cancer treated with radiotherapy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Gong F.F.
        • Peters A.C.
        • Malaisrie S.C.
        • et al.
        Optimal imaging guidance during transcatheter mitral valve-in-valve replacement in bioprostheses with radiolucent sewing rings.
        JACC Case Rep. 2020; 2: 1129-1134
        • Wamala I.
        • Unbehaun A.
        • Klein C.
        • et al.
        Real-time intraoperative co-registration of transesophageal echocardiography with fluoroscopy facilitates transcatheter mitral valve-in-valve implantation in cases of invisible degenerated bioprosthetic valves.
        Interact Cardiovasc Thorac Surg. 2021; 32: 695-702